Literature DB >> 8001140

Oncogenes and the strategy of growth factors.

R Baserga1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8001140     DOI： 10.1016/0092-8674(94)90023-x

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  47 in total

1.  Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

Authors:  P Burfeind; C L Chernicky; F Rininsland; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.

Authors:  Yasushi Adachi; Hirokazu Ohashi; Arisa Imsumran; Hiroyuki Yamamoto; Yasutaka Matsunaga; Hiroaki Taniguchi; Katsuhiko Nosho; Hiromu Suzuki; Yasushi Sasaki; Yoshiaki Arimura; David P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Tumour Biol       Date:  2013-09-13

Review 3.  ErbB receptors: from oncogenes to targeted cancer therapies.

Authors:  Hongtao Zhang; Alan Berezov; Qiang Wang; Geng Zhang; Jeffrey Drebin; Ramachandran Murali; Mark I Greene
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages.

Authors:  Q Liu; R W VanHoy; J H Zhou; R Dantzer; G G Freund; K W Kelley
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts.

Authors:  G M Fimia; V Gottifredi; B Bellei; M R Ricciardi; A Tafuri; P Amati; R Maione
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

6.  Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.

Authors:  Yasushi Adachi; Masanori Nojima; Mitsuru Mori; Yasutaka Matsunaga; Noriyuki Akutsu; Shigeru Sasaki; Takao Endo; Youichi Kurozawa; Kenji Wakai; Akiko Tamakoshi
Journal:  Tumour Biol       Date:  2016-09-23

7.  Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.

Authors:  M Paiardini; D Galati; B Cervasi; G Cannavo; L Galluzzi; M Montroni; D Guetard; M Magnani; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 9.  IGF-I receptor, cell-cell adhesion, tumour development and progression.

Authors:  Loredana Mauro; Eva Surmacz
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers.

Authors:  Yu Wang; Yasushi Adachi; Arisa Imsumran; Hiroyuki Yamamoto; Wenhua Piao; Hua Li; Masanori Ii; Yoshiaki Arimura; Mi Young Park; Dalrae Kim; Choon-Taek Lee; David P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2009-11-10       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.